Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blind Procedures02:07

Blind Procedures

13.5K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.5K
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

490
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
490
Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Survey Safety01:28

Survey Safety

410
Surveying near highways, rough terrain, or power lines involves significant risks. Working along highways is particularly dangerous and requires the use of warning signs and flagmen. It is safest to avoid working directly on roads and use offsets whenever possible. When highway work is unavoidable, it must follow all safety guidelines. Surveyors should wear bright clothing, such as orange reflective vests, to ensure visibility to motorists, coworkers, and hunters. In construction zones, wearing...
410
Relative Risk01:12

Relative Risk

2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Theory of Attribution I: Correspondent Inference Theory01:15

Theory of Attribution I: Correspondent Inference Theory

583
Correspondent inference theory, proposed by Jones and Davis in 1965, seeks to explain how individuals infer stable personality traits from observed behaviors. It suggests that people attribute actions to underlying dispositions rather than external circumstances, particularly when the behavior appears intentional and socially significant.Voluntary Behavior and Dispositional AttributionAccording to this theory, individuals are more likely to attribute behavior to personal traits when it appears...
583

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations.

Pharmaceutical statistics·2025
Same author

CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA·2025
Same author

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension.

EClinicalMedicine·2023
Same author

Inferential properties with a novel two parameter Poisson generalized Lindley distribution with regression and application to INAR(1) process.

Journal of biopharmaceutical statistics·2023
Same author

Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.

Journal of biopharmaceutical statistics·2022
Same author

Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning.

Statistics in biopharmaceutical research·2022

Related Experiment Video

Updated: Feb 5, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.1K

Bayesian detection of potential risk using inference on blinded safety data.

Saurabh Mukhopadhyay1, Brian Waterhouse1, Alan Hartford1

  • 1AbbVie Inc., North Chicago, IL, USA.

Pharmaceutical Statistics
|September 1, 2018
PubMed
Summary

This study introduces a novel Bayesian statistical method for detecting safety signals in blinded clinical trials. It helps assess risks of adverse events of special interest (AESI) before therapy approval.

Keywords:
Bayesian inferenceblinded monitoring of safety dataclinical trial

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Related Experiment Videos

Last Updated: Feb 5, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.1K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Area of Science:

  • Clinical Trials Methodology
  • Pharmacovigilance
  • Biostatistics

Background:

  • Regulatory bodies increasingly emphasize aggregate safety reviews for new therapies.
  • Assessing risks from blinded safety data during pre-approval is a significant challenge for sponsors.
  • Identifying safety signals early is crucial for patient safety.

Purpose of the Study:

  • To propose a novel quantitative statistical method for monitoring and detecting safety signals in blinded clinical trials.
  • To address the challenge of risk assessment using blinded safety data during the pre-approval period.
  • To specifically detect safety signals for adverse events of special interest (AESI) using historical background rates.

Main Methods:

  • A two-step Bayesian evaluation framework for safety signals.
  • Includes an initial screening analysis followed by a sensitivity analysis.
  • Utilizes historical data to establish background rates for AESI.

Main Results:

  • The proposed Bayesian modeling framework enables inference on relative risk in blinded trials.
  • The method effectively detects potential safety signals for AESI.
  • Provides a systematic approach for safety surveillance.

Conclusions:

  • The novel Bayesian method offers a sound quantitative approach for pre-approval safety surveillance.
  • Blinded safety teams can utilize this method to assess and escalate potential safety signals for unblinded review.
  • This facilitates proactive risk management in clinical trial development.